Daily BriefsEquity Bottom-Up

Daily Brief Equity Bottom-Up: L’Occitane (973 HK):  Underlying Fundamentals Intact and more

In today’s briefing:

  • L’Occitane (973 HK):  Underlying Fundamentals Intact
  • Globalfoundries Not Amused By TSMC’s European JV
  • [Week 1] Namaste India 🙏 | Whirlpool Stock Performance Is Good, Earnings Are Not
  • Trip.com Q223 Quick Take: Revenue, EPS > Consensus | Guidance? Not Much | Still No Upside Surprises
  • Komatsu (6301) | A Winning Bet on Onshoring and Electrification
  • Intel Does A Surprising Side Deal With Tower Semi
  • China Longyuan (916 HK): Value Has Definitely Emerged
  • Secure Trust Bank – One-off impairment masks underlying PBT beat
  • Medtronic (MDT US): Q1 Result Exceeds Forecast; FY24 Guidance Raised on Higher Surgery Volumes
  • 1Q Follow-Up – Takamiya (2445 JP)


L’Occitane (973 HK):  Underlying Fundamentals Intact

By Steve Zhou, CFA

  • L’Occitane (973 HK) announced after market close yesterday that the controlling shareholder has terminated the potential general offer. 
  • Shares trade at a significant discount to global cosmetics peers and its own historical trading range, while brands’ growth momentum remain intact. 
  • Take advantage of any potential significant sell-down caused by the drop of the privatization attempt. 

Globalfoundries Not Amused By TSMC’s European JV

By William Keating

  • Globalfoundries may be considering filing a complaint regarding TSMC’s recently announced European JV with three of their customers, Bosch, Infineon and NXP
  • Yet they just inked their own deal for a JV with ST Micro in France. What gives?
  • In conjunction with their recent CFO hiring fiasco, one wonders if all is well with the GF leadership team. 

[Week 1] Namaste India 🙏 | Whirlpool Stock Performance Is Good, Earnings Are Not

By Pranav Bhavsar


Trip.com Q223 Quick Take: Revenue, EPS > Consensus | Guidance? Not Much | Still No Upside Surprises

By Daniel Hellberg

  • Strong Q2 results out Tuesday morning beat consensus Revenue and core EPS estimates
  • But concerns remain about expense control and longevity of ongoing demand recovery
  • Great Q2 results, yes, but we think investors want more clarity about H2 demand

Komatsu (6301) | A Winning Bet on Onshoring and Electrification

By Mark Chadwick

  • We turned bullish on Komatsu a year ago and the stock has since returned over 50%.
  • Komatsu is trading at 10x EV/EBIT versus an historical average of 11x, with a target price of ¥5,100/share.
  • Komatsu represents a cheaper way to play the theme of onshoring and long-term mining demand from electrification.

Intel Does A Surprising Side Deal With Tower Semi

By William Keating

  • Tower Semi will pay Intel $300 million to acquire and own equipment and other fixed assets to be installed in the New Mexico facility
  • Intel’s termination fee on the failure of the proposed Tower Semi acquisition was $353 million
  • It’s quite the clever move and doesn’t require China’s approval…

China Longyuan (916 HK): Value Has Definitely Emerged

By Osbert Tang, CFA

  • China Longyuan Power (916 HK) is now attractively priced at 5.9x and 5.2x PERs for FY23 and FY24, respectively. The 2Q23 result clearly showed that business is gathering momentum.
  • Margins have demonstrated good improvement despite weaker tariffs and coal sale business. With a very low base in last year, its 2H23 earnings growth will be impressive.
  • There is positive progress on new project sign-up which has secured its pipeline. Asset injection from parent will stay as a major theme in the next two years.

Secure Trust Bank – One-off impairment masks underlying PBT beat

By Edison Investment Research

In its H123 results, Secure Trust Bank (STB) delivered an 11% y o y increase in operating income, overcoming margin pressure on rising interest rates. However, PBT was £16.5m, 4% lower than in H122 as the bank incurred a one-off impairment charge of £7.0m stemming from a long-standing debt case in Commercial Finance. Excluding this charge, PBT was £23.5m, which implies a 6% beat on our estimates on an annualised basis. Across the group, underlying impairments are resilient, especially in Vehicle Finance where impairments fell to 2.4% (H122: 8.0%) as lending shifted to prime borrowers. We have increased our FY23 and FY24 continuing PBT forecasts to £45m and £55m respectively, leaving the stock trading at P/E ratios of only 4.0x in FY23 and 3.1x in FY24.


Medtronic (MDT US): Q1 Result Exceeds Forecast; FY24 Guidance Raised on Higher Surgery Volumes

By Tina Banerjee

  • Medtronic Plc (MDT US) announced better-than-expected Q1FY24 result. Revenue of $7.7B increased 6% on organic basis, ahead of guidance of 4.5%. Each of four segments delivered 6% organic revenue growth.
  • Adjusted EPS increased 6% YoY to $1.20, ahead of guidance of $1.10–1.12. Outperformance was driven by better-than-expected operational performance and lesser-than-expected unfavorable impact from foreign currency translation.
  • The company increased FY24 organic revenue growth guidance to 4.5% versus the prior range of 4.0% to 4.5% and adjusted EPS guidance to $5.08–5.16, 7 cent increase at midpoint.

1Q Follow-Up – Takamiya (2445 JP)

By Sessa Investment Research

  • Takamiya announced its 1Q results for FY24/3 on August 4, after the close of trading.
  • Key figures on a consolidated basis were sales of ¥9,896 mn (+9.7% YoY), operating profit rose 125.5% YoY, to ¥409 mn, ordinary profit rose 41.0%YoY, to ¥615 mn, and quartery net profit rose 33.0%YoY, to ¥417 mn.
  • An overview by business segment is as follows

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars